Earnings call Quantinuum delivered Q2 2026 revenue of $8M, up 279% YoY, driven by cloud business growth and diversified customer mix. Management raised full-year 2026 revenue guidance to $28M–$32M and ...

LAGUNA HILLS, Calif. and SHANGHAI, Aug. 11, 2026 /PRNewswire/ -- Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug. 10, 2026. Granite Asia funded the first ...

Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic ...

9th Annual Program Honors the Marketing, Sales and AdTech Innovators Reshaping How Retail Brands Engage, Convert and Grow ...

Analysts warn of potential data collection, disruption and supply chain risks of depending on China for optical transceivers.

We've spent 20 years measuring what happens after a query is made. AI exposes why that's no longer enough.

CenterPoint Energy (CNP) benefits from Houston power demand, but financing/dilution and rich valuation limit upside.

Buy APP. The top-line miss looks like timing of Axon AI upgrades (deferred revenue), while profitability is strong: Q2 free ...

The partnership engine reached this milestone with zero paid ads, proving that for founders priced out of the acquisition ...

Recursive Self-Improvement in AI: From Bounded Self-Refinement to Autonomous Research Loops (July 2026) Unlimited ...

Q2’26 ad revenue +27% YoY and $140B AI CapEx fuel long-term upside beyond ads. Click here to read this analysis.

AI drug discovery startup Aureka Biotechnologies closed a $100 million Series B on August 10, 2026, backed by an open-source ...